Haleon plc ADR vs Teva- Pharmaceutical Industries Ltd

Haleon plc ADR (HLN) is overvalued and Teva- Pharmaceutical Industries Ltd (TEVA) is overvalued.

Both trade above our estimate of their intrinsic value. HLN is the closer of the two: -22%, against -110% for TEVA.

Values as of the 17 Nov 2026 close.

Haleon plc ADR (HLN)

Discounting its cash flows at 8.9% (average of 3 methods) values the shares at $7.44; the price of $9.05 is 22% above that value, and 76% of that value comes from beyond year five.

Leak Score: free with an account

Teva- Pharmaceutical Industries Ltd (TEVA)

Discounting its cash flows at 9.7% (average of 3 methods) values the shares at $20.28; the price of $42.62 is 110% above that value, and 73% of that value comes from beyond year five.

Leak Score: free with an account

MetricHLNTEVA
VerdictOvervaluedOvervalued
Price$9.05$42.62
Intrinsic value$7.44$20.28
Margin of safety-22%-110%
Market cap$39.7B$49.7B
Revenue growth, 5 years2.8%0.8%
Operating margin23.3%19.2%
Net margin14.6%2.9%
Return on equity10.0%6.7%
Debt to equity0.502.13
P/E18.6x100.3x
Forward P/E15.2x13.7x
P/B1.8x6.2x
Dividend yield2.4%—

All stocks in Drug Manufacturers - Specialty & Generic